Blood Level Omega-3 Fatty Acids as Risk Determinant Molecular Biomarker for Prostate Cancer

被引:11
|
作者
Sorongon-Legaspi, Mishell Kris [1 ]
Chua, Michael [2 ]
Sio, Maria Christina [3 ]
Morales, Marcelino, Jr. [1 ]
机构
[1] St Lukes Coll Med, Dept Prevent & Community Med, Quezon City 1102, Philippines
[2] St Lukes Med Ctr, Inst Urol, 279 E Rodriguez Blvd,Cathedral Hts, Quezon City 1102, Philippines
[3] St Lukes Med Ctr, Dept Head Ear Neck & Throat, Quezon City 1102, Philippines
关键词
D O I
10.1155/2013/875615
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous researches involving dietary methods have shown conflicting findings. Authors sought to assess the association of prostate cancer risk with blood levels of omega-3 polyunsaturated fatty acids (n-3 PUFA) through a meta-analysis of human epidemiological studies in available online databases (July, 2012). After critical appraisal by two independent reviewers, Newcastle-Ottawa Quality Assessment Scale (NOQAS) was used to grade the studies. Six case control and six nested case control studies were included. Results showed nonsignificant association of overall effect estimates with total or advanced prostate cancer or high-grade tumor. High blood level of alpha-linolenic acid (ALA) had nonsignificant positive association with total prostate cancer risk. High blood level of docosapentaenoic acid (DPA) had significant negative association with total prostate cancer risk. Specific n-3 PUFA in fish oil, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) had positive association with high-grade prostate tumor risk only after adjustment of interstudy variability. There is evidence that high blood level of DPA that is linked with reduced total prostate cancer risk and elevated blood levels of fish oils, EPA, and DHA is associated with high-grade prostate tumor, but careful interpretation is needed due to intricate details involved in prostate carcinogenesis and N-3 PUFA metabolism.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk
    Hopkins M.M.
    Meier K.E.
    [J]. Current Nutrition Reports, 2016, 5 (1) : 34 - 40
  • [2] Prediagnostic level of fatty acids in serum phospholipids: Omega-3 and Omega-6 fatty acids and the risk of prostate cancer
    Harvei, S
    Bjerve, KS
    Tretli, S
    Jellum, E
    Robsahm, TE
    Vatten, L
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1997, 71 (04) : 545 - 551
  • [3] Study Links Omega-3 Fatty Acids and Prostate Cancer Risk
    不详
    [J]. ONCOLOGY-NEW YORK, 2013, 27 (08): : 813 - 813
  • [4] Omega-3 fatty acids and cancer risk - Reply
    MacLean, Catherine H.
    Newberry, Sydne J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (03): : 282 - 282
  • [5] Molecular Level Membrane Modulation by Omega-3 Fatty Acids
    Ayee, Manuela A. A.
    Bunker, Brendan C.
    De Groot, Jordan L.
    [J]. BIOPHYSICAL JOURNAL, 2021, 120 (03) : 323A - 324A
  • [6] Omega-3 fatty acids in cancer
    Laviano, Alessandro
    Rianda, Serena
    Molfino, Alessio
    Rossi Fanelli, Filippo
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2013, 16 (02): : 156 - 161
  • [7] Molecular Targets of Omega-3 Fatty Acids for Cancer Therapy
    Devi, K. Pandima
    Rajavel, T.
    Russo, G. L.
    Daglia, M.
    Nabavi, S. F.
    Nabavi, S. M.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (07) : 888 - 895
  • [8] Importance of long chain omega-3 fatty acids in prostate cancer
    de Gaudry, D. Kuellenberg
    Massing, U.
    [J]. UROLOGE, 2014, 53 (11): : 1620 - 1624
  • [9] Mechanisms of Omega-3 Polyunsaturated Fatty Acids in Prostate Cancer Prevention
    Gu, Zhennan
    Suburu, Janel
    Chen, Haiqin
    Chen, Yong Q.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [10] OMEGA-3 FATTY ACIDS AND BLOOD PRESSURE
    Mori, T. A.
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2010, 56 (01) : 83 - 92